Form 4: CalciMedica Director Acquires Shares

Fred A. Middleton, a Director and 10% Owner of CalciMedica, Inc., acquired 248,972 shares of common stock on June 25, 2026, through a Securities Purchase Agreement.

Summary

• Fred A. Middleton, a Director and 10% Owner of CalciMedica, Inc., acquired 248,972 shares of common stock on June 25, 2026.
• The acquisition was made at a price of $0.8033 per share, totaling an investment of approximately $200,000.
• Following this transaction, Middleton's beneficial ownership of CalciMedica common stock increased significantly, with a substantial portion held indirectly through various Sanderling Ventures funds and Golden Triangle Ventures, LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports an insider's stock acquisition without providing company performance or strategic updates.

Positives

• Director and significant owner Fred A. Middleton has increased his stake in CalciMedica, Inc., demonstrating personal investment and confidence in the company.
• The acquisition was made pursuant to a Securities Purchase Agreement approved by an independent committee of the Issuer's Board of Directors, suggesting a well-governed transaction.
• The transaction involved the purchase of common stock, indicating a direct investment in the company's equity.

Negatives

• The filing does not provide details on the company's financial performance or strategic updates, focusing solely on a change in beneficial ownership.
• The majority of Middleton's beneficial ownership is indirect, held through multiple investment entities, which may dilute direct control or influence.

Risks

• The filing does not explicitly mention any risks associated with this transaction or the company's operations.
• Indirect beneficial ownership through various funds could introduce complexities in reporting and potential conflicts of interest, though not explicitly stated as a risk.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein (repeated for multiple entities).

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from CalciMedica, Inc., are standard disclosures for insider transactions. Such filings are crucial for understanding insider confidence and potential shifts in ownership structure within the biotechnology sector, where CalciMedica operates.

Corporate Governance

Related Party Transactions

• Fred A. Middleton, a Director and 10% Owner, acquired shares through a Securities Purchase Agreement, which was approved by an independent committee of the Board of Directors.

Stakeholder Impact

• Shareholders: The acquisition by a director and 10% owner may be viewed positively, signaling confidence, but the lack of performance data limits immediate impact.
• Management: Reinforces the alignment of interests between key insiders and the company's equity.

Next Steps

• Continued monitoring of insider transactions and subsequent filings for CalciMedica, Inc.

Key Dates

Keywords

CalciMedica, CALC, Form 4, Beneficial Ownership, Securities Purchase Agreement, Fred A. Middleton, Director, 10% Owner, Common Stock, Sanderling Ventures